Legal Representation
Attorney
Paul Grandinetti
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 6, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Jun 6, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Nov 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 7, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 7, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Aug 18, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 5, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 5, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jul 5, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Jul 5, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jul 5, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 22, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 22, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jun 22, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jun 22, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 21, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 10, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Dec 26, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations containing iron for the treatment of iron deficiency and anemia; Pharmaceutical medications containing endopeptidases for the treatment of gluten intolerance
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "ENTERALIA" has no meaning in a foreign language.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOSCIENCE"